NCT02892188

Brief Summary

The purpose of this study is to evaluate the follow-up of the osteoporotic patient by a physician-pharmacist collaboration.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
3.7 years until next milestone

First Submitted

Initial submission to the registry

August 26, 2016

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 8, 2016

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2019

Completed
Last Updated

January 2, 2020

Status Verified

December 1, 2019

Enrollment Period

6 years

First QC Date

August 26, 2016

Last Update Submit

December 31, 2019

Conditions

Osteoporosis

Outcome Measures

Primary Outcomes (1)

  • Respect of treatment and of hygienic dietary measures by patients with a self-questionnaire per medical check

    This assessment will be made at the end of the follow-up, after three years, but an intermediary assessment about those same criteria is planned at one and two years of the follow-up.

    year 3

Secondary Outcomes (2)

  • Qualitative evaluation of the professional adhesion for the follow-up process once a year during the annual meeting

    year 3

  • Quantitative evaluation of it by the return rate of questionnaires

    year 3

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patient having osteoporosis enrolled into the programm of Therapeutical Educational for patient

You may qualify if:

  • older than 18 years old
  • having an osteoporosis treatment
  • following a Therapeutical Education for Patient

You may not qualify if:

  • opposition for anonymised data gathering

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHR Metz-Thionville

Metz, 57085, France

Location

MeSH Terms

Conditions

Osteoporosis

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Didier POIVRET, MD

    CHR Metz-Thionville

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 26, 2016

First Posted

September 8, 2016

Study Start

January 1, 2013

Primary Completion

January 1, 2019

Study Completion

February 1, 2019

Last Updated

January 2, 2020

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)